Cardiometabolic health describes the close connection between the heart, circulation, metabolism, body weight, inflammation, and nutrition. For dogs and cats, heart health is not limited to the heart muscle alone. The kidneys, liver, digestive tract, blood vessels, adrenal glands, nervous system, and blood all contribute to normal cardiovascular function.
A veterinary diagnosis and treatment plan should always come first when heart disease is suspected or confirmed. Nutrition can then be an important part of whole-pet support, helping maintain appropriate body condition and provide nutrients involved in cardiac energy metabolism, antioxidant defenses, and inflammatory balance.
Heart disease occurs in both dogs and cats, though the most common forms differ by species. In dogs, chronic valvular heart disease is a leading condition and is seen especially in smaller breeds. Dilated cardiomyopathy, commonly called DCM, is another major canine heart condition and is more commonly associated with larger dogs.
In adult cats, hypertrophic cardiomyopathy is the most common diagnosed heart condition. Although age increases the likelihood of cardiac dysfunction across breeds, genetics and breed-related conditions can contribute to earlier cardiac concerns in younger animals.
Early identification and broad cardiovascular support matter because the cardiovascular system depends on multiple organs working together:
Maintaining an appropriate body condition from an early age is one of the most practical ways to support long-term cardiometabolic health. Overfeeding can gradually lead to excess weight, and overweight or obesity is common in pet populations.
Obesity in dogs is associated with changes in cardiac structure and function, as well as insulin resistance, altered blood lipids, lower adiponectin concentrations, and higher inflammatory markers. Abdominal fat accumulation is particularly relevant because it is associated with heart disease in dogs.
Dietary needs should be individualized, particularly for pets with diagnosed heart disease, chronic heart failure, changes in appetite, or multiple health conditions. In general, nutritional priorities discussed for pets at risk of cardiometabolic disease include adequate protein intake, appropriate sodium management, and sufficient levels of nutrients involved in taurine production, energy metabolism, and antioxidant activity.
A common mistake is assuming that every pet with a cardiac concern needs the same diet or supplement plan. Species, body size, disease type, concurrent medications, appetite, weight, and current food all matter. Do not make major diet changes or add concentrated supplements without veterinary guidance.
Low-protein diets and diets providing inadequate taurine or bioavailable sulfur-containing amino acids—particularly methionine and cysteine—have been associated with taurine deficiency and DCM in some dogs. Methionine and cysteine are important because dogs use these amino acids as precursors for endogenous taurine synthesis.
Low total protein itself isn't necessarily the problem. The concern is whether the diet supplies adequate amounts and bioavailability of the relevant amino acids. So we don’t want to imply that low protein automatically causes DCM.
Dogs can synthesize taurine in the liver from cysteine, but the rate of taurine production may vary by breed and body size. Research discussed in this context found lower taurine biosynthesis in larger mixed-breed dogs than in smaller dogs, even when both groups received adequate protein and sulfur-containing amino acids. This makes diet evaluation especially important for large dogs with cardiac risk factors.
Taurine has several cardiac roles. It helps regulate fluid balance within cells, influences intracellular calcium, and has antioxidant-related functions. Cats require taurine from their diet because their ability to produce it from cysteine is limited. Historically, taurine supplementation in feline diets dramatically reduced the frequency of taurine-deficiency-related DCM.
Animal-based foods are important taurine sources. Beef, chicken, salmon, and beef liver were identified as food sources containing taurine. Whole-blood taurine concentrations in dogs have also been found to vary with dietary patterns, reinforcing the need to assess a pet's full diet rather than relying on a single ingredient claim.
Carnitine helps transport long-chain fatty acids into the mitochondria, where they can be broken down to generate energy. This matters for the heart because a substantial share of cardiac energy production comes from fatty-acid beta oxidation.
Carnitine also helps buffer potentially harmful acyl-CoA accumulation in mitochondria, supporting continued energy metabolism. Animal-derived foods are the primary dietary sources of carnitine discussed for pets.
Choline is an essential nutrient often grouped with B vitamins. Its metabolite, betaine, serves as a methyl donor in the pathway that regenerates methionine from homocysteine. When choline stores are inadequate, that conversion capacity may be reduced and homocysteine may accumulate.
Because methionine, cysteine, and taurine pathways are connected, choline is one of several nutrients worth considering when a veterinarian reviews the nutritional status of a pet with cardiometabolic concerns.
Vitamin E is a major fat-soluble antioxidant. Selenium serves as a cofactor for glutathione-related antioxidant activity, including glutathione peroxidase. This enzyme helps neutralize free radicals and protect polyunsaturated fats from oxidative damage.
Dogs with DCM have been reported to have lower vitamin E concentrations and reduced glutathione peroxidase activity compared with healthy dogs. These findings support the importance of reviewing overall dietary adequacy rather than focusing only on calories or protein.
Several additional dietary factors play supporting roles:
Phytonutrients are plant-derived compounds that can support health through a range of bioactive effects. Flavonoids and phenolic acids can support antioxidant activity and may function as antioxidants themselves.
Whole-food sources are notable because compounds within a plant can work together. This potential synergy is one reason that a complete, appropriately formulated diet remains the starting point for nutritional support.
Polyphenols have been associated with beneficial effects on lipid profiles, endothelial function, glucose metabolism, beta-cell function, blood pressure, oxidative stress markers, and inflammation. These functions are all relevant to the broader cardiometabolic picture.
Omega-3 fatty acids are among the most discussed nutritional tools for cardiovascular support in pets. The key omega-3 fats are alpha-linolenic acid, or ALA, plus the longer-chain fatty acids EPA and DHA.
Dogs convert ALA to EPA and DHA inefficiently, while this conversion is essentially absent in cats. As a result, EPA and DHA are particularly important considerations when evaluating omega-3 nutrition in either species.
Many pet diets contain more omega-6 fatty acids than omega-3 fatty acids. Omega-6 fats tend to support pro-inflammatory pathways, whereas omega-3 fats are generally associated with anti-inflammatory activity. EPA and DHA are not required in commercial pet foods, so their amounts may vary substantially among foods.
EPA and DHA have been associated with support for dogs with cardiac disease through anti-inflammatory and anti-arrhythmic effects, support for myocardial energy metabolism and endothelial function, and help managing loss of lean body mass. In dogs with chronic heart failure, EPA and DHA have also been associated with better food intake and reduced cachexia.
A small study of boxers with arrhythmogenic right ventricular cardiomyopathy compared fish oil providing EPA and DHA, flax oil providing ALA, and a control. After six weeks, reduced ventricular premature contractions were observed only in the fish-oil group. This illustrates why the source and form of omega-3 matter.
Omega-3 testing can measure fatty acids in canine red blood cells using a dried blood spot sample. This may help a veterinary professional identify low omega-3 status and make more informed supplementation decisions. At the time discussed here, this testing approach was available for dogs rather than cats.
Prescription cardiac therapies may include medication categories such as ACE inhibitors and phosphodiesterase inhibitors. These medications can help address blood vessel constriction, strengthen cardiac contractions, or provide vasodilation depending on the clinical situation.
Nutritional support is complementary. It should not be used to discontinue medication, delay diagnostics, or manage a serious cardiac condition independently. As medication needs increase, veterinary oversight becomes even more important because drug side effects and toxicity risks can become part of the treatment picture.
Targeted veterinary cardiac products may combine nutrients such as L-carnitine, organ-derived ingredients, B vitamins, selenium, vitamin E, potassium, and other food-based ingredients. Species-specific formulas may differ because dogs are omnivorous while cats are more carnivorous and may benefit from formulas with different concentrations of organ and glandular tissues.
When comparing products, avoid combining multiple cardiac formulas automatically. Overlapping ingredients can make it difficult to assess total nutrient intake. A veterinarian can help determine whether one broad formula, a targeted nutrient, or no supplement is the appropriate choice.
Start with the basics: maintain an appropriate body condition, use a complete diet suited to the pet's species and life stage, and discuss any cardiac risk factors with a veterinarian. For pets with diagnosed heart disease, a structured review of protein, sodium, taurine-related nutrients, omega-3 intake, antioxidant support, appetite, and lean body mass can guide a more individualized plan.
The most useful approach is not a single ingredient. It is a coordinated plan that considers the pet's disease status, current diet, medications, body weight, clinical monitoring, and nutrient needs together.
It refers to the relationship between cardiovascular function and metabolism. It includes the heart and blood vessels, along with body weight, inflammation, nutrient intake, energy metabolism, and the contributions of organs such as the kidneys, liver, digestive tract, adrenal glands, and bone marrow.
Yes. Taurine is essential in cats because they have limited ability to synthesize it. Dogs can produce taurine from cysteine, but dietary protein quality, sulfur-containing amino acids, body size, and breed-related differences in taurine production may be relevant, particularly when evaluating DCM risk.
No. Flax provides ALA, while fish oil can provide EPA and DHA directly. Dogs convert ALA to EPA and DHA inefficiently, and cats have very limited to no meaningful conversion. EPA and DHA are therefore distinct nutritional considerations for canine and feline heart support.
Maintaining a healthy body condition can reduce a major cardiometabolic risk factor. Obesity in dogs is associated with changes in cardiac structure and function, insulin resistance, altered lipids, and increased inflammatory markers. Any weight-loss plan should be tailored with veterinary guidance, especially for a pet with heart disease.